104 Results (Page 1 of 9)
UK Markets Research Reports
UK Artificial Intelligence (AI) in Healthcare Market Analysis
The UK Artificial Intelligence (AI) In Healthcare Market is projected to grow from $0.18 Bn in 2022 to $3.18 Bn by 2030, registering a CAGR of 43.22% during the forecast period of 2022 - 2030. The market will be driven by. The market is segmented by healthcare components & by healthcare applications. Some of the major players include NVIDIA Corporation, GE Healthcare & Google DeepMind Health.
UK Healthcare Claims Management Market Analysis
The UK healthcare claims management market is projected to grow from $694.2 Mn in 2022 to $3275.17 Mn by 2030, registering a CAGR of 21.4% during the forecast period of 2022 - 2030. The main factors driving the growth would be increasing demand for healthcare services, rising healthcare costs, increasing use of Electronic Health Records (EHRs) and advances in technology. The market is segmented by component, type, by delivery mode and end-user. Some of the major players include Healthcode, WNS, Healix Health Services, Cognizant, Allscripts Healthcare and McKesson.
UK Anti Aging Therapeutics Market Analysis
UK anti-aging therapeutics market is projected to grow from $16 Mn in 2022 to $46 Mn in 2030 with a CAGR of 14.53% for the year 2022-2030. The rising geriatric population, increasing demand for anti-aging therapeutics, and rising healthcare expenditure are the major market drivers for the growth of the market. The UK anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Some of the key players in the market include Veristat, Genflow Biosciences, and Regenerative Medicine.
UK Healthcare Financial Analytics Market Analysis
The UK Healthcare Financial Analytics market size was valued at $xx Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 4.8% from 2022 to 2030 and will reach $xx Mn in 2030. The market is segmented by type, component, and deployment. UK’s Healthcare Financial Analytics market will grow the adoption of EHRs has been increasing in the UK healthcare sector. Financial analytics solutions can integrate with EHRs to provide a comprehensive view of a patient's health history and enable better decision-making. The key market players are Draper & Dash, MedeAnalytics, Informatics Merseyside, EY, and others.
UK ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Analysis
The UK Attention Deficit Hyperactivity Disorder (ADHD) therapeutics market is projected to grow from $769 Mn in 2022 to $1,179 Mn in 2030 with a CAGR of 5.5% for the year 2022-30 as there is an increase in awareness in the diagnosis and treatment for ADHD as well as availability of new therapeutic options in UK. The UK ADHD therapeutics market is segmented by drug, drug type, demographics, and by distribution channel. Colonis Pharma, Shire, and Advanz Pharmaceuticals are the key players in the market.
UK 3D Printing Medical Devices Market Analysis
The UK 3D Printing Medical Devices market size was valued at $77 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 14.3% from 2022 to 2030 and will reach $ 225 Mn in 2030. The market is segmented by component, application, , technology, and end user. The UK 3D Printing Medical Devices market will grow as the development of new 3D printing materials and techniques has led to the production of more complex and customizable medical devices. The key market players are Renishaw plc, Sutrue, Axial3D, Adapttech, FDM Digital Solutions, 3D LifePrints, Opro Mouthguards, Toffeln, PrintLab, Added Scientific and others.
UK Healthcare Insurance Market Analysis
The UK healthcare insurance market is projected to grow from $52.68 Bn in 2022 to $81.46 Bn by 2030, registering a CAGR of 5.6% during the forecast period of 2022 - 2030. The main factors driving the growth would be the rising cost of medical services, the increasing number of daycare procedures and government initiatives. The market is segmented by component, the provider, coverage, health insurance plans and end-user. Some of the major players include Bupa, Aviva, VitalityHealth, Simplyhealth and Saga.
UK Home Healthcare Market Analysis
The UK Home Healthcare Market is projected to grow from $9.429 Bn in 2022 to $14.494 Bn by 2030, registering a CAGR of 5.93% during the forecast period of 2022 - 2030. The demand for home healthcare systems in the UK has been significantly impacted by the rising prevalence of chronic diseases. One of the main reasons for the expansion of the UK home healthcare business has been the rise in mergers and acquisitions. Some key players in the UK home healthcare market include Bupa, Care UK, Barchester Healthcare, Four Seasons Health Care, and HC-One.
UK Dialysis Market Analysis
The UK dialysis market size was valued at $3.02 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 6.4% from 2022 to 2030 and will reach $4.5 Bn in 2030. Some of the major factors driving the market are increased funding for the research of novel medications, and an increase in patients with end-stage renal disease (ESRD). The market is segmented by Type, Product and Services, and End User. The major market players in UK dialysis market are DaVita, Baxter, Medtronic, Fresenius Kabi, Physidia, and others.
UK Liver Diseases Therapeutics Market Analysis
By 2030, it is anticipated that the UK Liver Disease Therapeutics market will reach a value of $803 Mn from $600 Mn in 2022, growing at a CAGR of 3.7% during 2022-2030. Liver Disease Therapeutics in the UK is dominated by a few domestic pharmaceutical companies such as Intercept Pharmaceuticals, Gilead Sciences, AstraZeneca and Shire. The Liver Disease Therapeutics market in the UK is segmented into different types of disease and different therapy types. Some of the major factors affecting the UK Liver Disease Therapeutics market are the growing prevalence of liver diseases and unhealthy and dynamic lifestyles.
UK Oncology Clinical Trials Market Analysis
The UK oncology clinical trials market is projected to grow from $328.9 Mn in 2022 to $433.1 Mn by 2030, registering a CAGR of 3.50% during the forecast period of 2022-30. The market will be driven by the rising incidence of cancer in the UK and efforts to promote research, collaboration, and innovation. The market is segmented by phase, study design, and indication. Some of the major players include Novartis AG, AstraZeneca & Astex Pharmaceuticals.
UK Oral Care Market Analysis
The UK Oral Care market was valued at $916 Mn in 2022 and is estimated to expand at a CAGR of 4.2% from 2022 to 2030 and will reach $1273 Mn in 2030. One of the main reasons propelling the growth of this market is Rising Demand for Cosmetic Dentistry, Technological Advancements. The market is segmented by type, drug and distribution channel. Some key players in this market are Wisdom Toothbrushes, Curaprox UK, Oralieve, DenTek, Lush UltraDEX, Waken among others.
UK Multiple Myeloma Therapeutics Market Analysis
The UK Multiple Myeloma Therapeutics Market was valued at $217 Mn in 2022 and is estimated to expand at a CAGR of 2.5% from 2022 to 2030 and will reach $264 Mn in 2030. One of the main reasons propelling the growth of this Market is increase in chronic disease, aging population. The Market is segmented by type, drug and distribution channel. Some key players in this Market are Takeda, Amgen, Janssen-Cilag, Celgene, AstraZeneca and others.
UK Diabetes Drugs Market Analysis
The UK diabetes drugs market size was valued at $1.6 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 4.1% from 2022 to 2030 and will reach $2.21 Bn in 2030. The market is segmented by drug type, application, and distribution channel. The UK diabetes drug market will grow because UK has a strong pharmaceutical industry with several established companies and emerging biotech companies developing new diabetes drugs. The key market players are AstraZeneca, GlaxoSmithKline, Eli Lilly and Company, Novo Nordisk, Sanofi, and others.
UK Connected Healthcare Market Analysis
The UK-connected healthcare market is projected to grow from $1.73 Bn in 2022 to $11.24 Bn by 2030, registering a CAGR of 26.24% during the forecast period of 2022 - 2030. The main factors driving the growth would be the ageing population, advances in technology, the COVID-19 pandemic and regulatory support. The market is segmented by type, function and by application. Some of the major players include Babylon Health, Huma, Livi, Pudh Doctor, Cera Care, Apple, Microsoft, IBM and GE Healthcare.
UK Robotic Surgery Services Market Analysis
UK robotic surgery service market size was valued at $112 Mn in 2022 and is estimated to expand at a CAGR of 17.30% from 2022-30 and will reach $400 Mn in 2030. The robotic surgery service market will grow due to Robotic surgical systems providing physicians with greater accuracy and precision, which results in improved patient outcomes and reduced complications. The market is segmented by product and service type, application type, and end user. Some of the major players are Intuitive Surgical, Smith & Nephew, TransEnterix Surgical, Inc., Renishaw plc., and others
UK Neurology Clinical Trials Market Analysis
The UK Neurology Clinical Trials market is projected to grow from $342.2 Mn in 2022 to $451.4 Mn by 2030, registering a CAGR of 3.52% during the forecast period of 2022 - 2030. The market will be driven by increasing funding and assistance from institutions such as the NIHR as well as greater awareness and understanding of neurological disorders. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer Inc., Biogen Inc & Cambridge Cognition Holdings PLC.
UK Artificial Intelligence (AI) in Medical Imaging Market Analysis
The UK Artificial Intelligence (AI) in Medical Imaging market size was valued at $39 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 33.4% from 2022 to 2030 and will reach $391 Mn. The market is segmented by AI technology, solution, modality, application, and end User. The UK Artificial Intelligence (AI) in the Medical Imaging market will grow due to AI technologies can help improve the accuracy and efficiency of medical imaging, leading to better patient outcomes and reduced healthcare costs. Some of the key players in this market are Optellum, Kheiron Medical, Aidoc, Sophia Genetics, Ultromics, Brainomix, MaxQ AI, Faculty, Sensyne Health, Feedback Medical, Cambridge Medical Imaging, Perspectum, Oxipit, Qure.ai, Quantib, Imagen, Mirada Medical, Kromek Group, GTN, 4D Imaging,and others.
UK Primary Hyperoxaluria (PH) Therapeutics Market Analysis
The UK Primary Hyperoxaluria (PH) therapeutics market was valued at $XX Bn in 2022 and is estimated to expand at a CAGR of 2.8% from 2022 to 2030 and will reach $XX Bn in 2030. One of the main reasons propelling the growth of this market is government initiatives and an aging population. The market is segmented by diagnostic method, by treatment, and by type. Some key players in this market are Alnylam Pharmaceuticals, Dicerna Pharmaceuticals, OxThera, Orphan Europe, and Ultragenyx Pharmaceutical, among others.
UK Alzheimer’s Disease Drugs Market Analysis
The UK Alzheimer’s disease drugs market was valued at $401 Mn in 2022 and is estimated to expand at a CAGR of 6.42% from 2022-30 and will reach $660 Mn in 2030. One of the main reasons propelling the growth of this market is the introduction of newer technologies, and the aging population. The market is segmented by drug classes and by Distribution Channels. Some key players in this market are AbbVie, AstraZeneca, Accord Healthcare, Aesica Queenborough, Allen & Hanburys, Biogen, Daiichi Sankyo Company, Eisai Co., Eli Lilly and Company, Johnson and Johnson, H. Lundbeck A/S, F. Hoffmann-La Roche AG, Merck & Co., Novartis AG, Ono Pharmaceutical Co., Pfizer and Teva Pharmaceutical among others.
UK Infectious Disease Therapeutics Market Analysis
By 2030, it is anticipated that the UK infectious disease therapeutics market will reach a value of $3.75 Bn from $3.12 Bn in 2022, growing at a CAGR of 2.4% during 2022-2030. Infectious Disease Therapeutics in the UK is dominated by a few domestic pharmaceutical companies such as GlaxoSmithKline, Faron Pharmaceuticals and Emergent BioSolutions. The infectious disease therapeutics market in the UK is segmented into different therapeutic areas and different treatment types. The major factors affecting the UK infectious disease therapeutics market are the increasing disease burden of communicable diseases like TB, hepatitis, and COVID-19 and the lack of healthcare funding for infectious disease treatment in various areas of the UK.
UK Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market Analysis
The UK COPD Therapeutics Market was valued at $475 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 5.1% from 2022 to 2030 and will reach $706 Mn in 2030. One of the main reasons propelling the growth of this market is increase prevalence rate, government initiative. The market is segmented by Drug class and By distribution channel. Some key players in this market are Verona Pharma, GlaxoSmithKline, AstraZeneca, Chiesi, Boehringer Ingelheim, Teva Pharmaceuticals, Novartis, Pfizer, Merck and others.
UK Clinical Diagnostics Market Analysis
The UK Clinical Diagnostic market was valued at $1.79 Bn in 2022 and is estimated to expand at a CAGR of 4% from 2022-30 and will reach $2.45 Bn in 2030. One of the main reasons propelling the growth of this market is an increase in chronic disease and government support. The market is segmented by type, drug, and distribution channel. Some key players in this market are Abbott, Omega Diagnostics, Quest Diagnostics, F. Hoffmann-La Roche, LumiraDx, Diagnostics.ai, Thermo Fisher Scientific, Danaher Corporation, and others.
UK Patient Support Programs (PSP) Market Analysis
The UK Patient Support Programs (PSP) market is expected to grow from $xx Bn in 2022 to $xx Bn in 2030 with a CAGR of 7.9% for the year 2022-2030. Rising technological advancements as well as increased investments in the PSP segments by the pharmaceutical companies in the UK are the major drivers of the UK Patient Support Programs (PSP) market. The market is segmented by functionality outlook, therapeutic outlook, application outlook, and end user. Wren Healthcare, Alcura, and Atlantis Healthcare are some of the major operators in the UK Patient Support Programs (PSP) market.
UK Acne Therapeutics Market Analysis
As Acne vulgaris continues to affect almost 34% of adults in the UK, the UK acne therapeutics market is expected to grow from $261 Mn in 2022 to $377 Mn in 2030 with a CAGR of 4.7% for the year 2022-2030. Revolutionary acne therapeutics options and acne awareness campaigns in the UK are responsible for the growth of the UK acne therapeutics market. The market is segmented by treatment, route of administration, age group, and by distribution channel. Chugai, Chatfield, and Takeda are some of the key competitors in the UK acne therapeutics market.